Science advisory board

Dr. Gauguier is a leading expert in metabolic disease genetics and a pioneer in the discovery of 4-Cresol's therapeutic potential. He is Director of Research at INSERM (Université Paris–Cité), and holds visiting and adjunct positions at Imperial College London, Kyoto University, and McGill University. He earned his Ph.D. in human nutrition in Paris and previously served as Professor of Mammalian Genetics at Oxford University.

Dr. Matsuda has extensive experience in genomics and headed the Centre National de Génotypage and held a double appointment as Professor at Kyoto University and Directeur de Recherche of INSERM. He is a Knight of the National Order of Merit and also received the Chevalier de l'Ordre des Palmes Académiques. He earned his Ph.D. from the Kyoto University Graduate School of Medicine.

Dr. Wood is a distinguished expert in clinical pharmacology with extensive leadership in biotech and pharmaceutical companies. He is Executive Vice-President for NuvoSelex Network (U.S.), overseeing U.S. operations and services. Dr. Wood earned his Ph.D. in Neurology and Neurosurgery at McGill University and a B.Sc. in Biochemistry (Summa Cum Laude) from McMaster University.

Dr. Ogawa is a prolific microbiologist and professor at Kyoto University who has been a visiting scholar at the Institut National de la Recherche Agronomique in France. Dr. Ogawa's research covers applied microbiology, microbial biochemistry, microbial physiology, fermentation physiology, enzyme engineering, environmental microbiology, and microbial molecular biology. He obtained his Ph.D. at the Graduate School of Agriculture at Kyoto University.

Dr. Auld brings 20+ years of experience in neuroscience, drug development, and research leadership. He leads operations at McGill's Victor Phillip Dahdaleh Institute of Genomic Medicine (2011–2026). He is a graduate of the adMare Executive Academy. He earned his Ph.D. in Neurology at McGill University.